Introduction
Pulmonary carcinoid tumors are neuroendocrine malignant tumors that represent 1% to 2% of all lung tumors. According to histopathologic criteria, carcinoids could be divided into typical (TC) and atypical (AC) carcinoids. Carcinoids are in a spectrum of neuroendocrine tumors, ranging from low-grade malignant TC, intermediate AC, high-grade large cell neuroendocrine carcinoma to small cell lung carcinoma. Familial pulmonary carcinoids are rare. The most common symptoms are hemoptysis, cough, recurrent pulmonary infection, fever, chest discomfort and chest pain, unilateral wheezing, and shortness of breath. Paraneoplastic syndromes are rare and include carcinoid syndrome, Cushing's syndrome, and ectopic growth hormone secretion. The diagnosis is usually established by flexible bronchoscopy and biopsy, although occasionally this can result in severe hemorrhage. Immunoscintigraphy by somatostatin analogues can also help in the diagnosis. The treatment of choice is surgical resection, and prognosis is relatively good for TC, though it is not usually favorable for AC. The role of radiotherapy and chemotherapy as a part of multimodality treatment or palliation is still debated. 1) This study was aimed to assess the result of treatment and 3-year survival rate of patients with carcinoid tumors.
Materials and Methods
This is a descriptive study which was performed on 40 patients admitted to Qhaem and Omid hospitals of Mashhad University of Medical Sciences from 1990 to 2007. They were evaluated after appropriate treatment (38 patients had undergone surgery and 2 patients underwent chemoradiotherapy without surgery because of distant metastasis at the time of admission). They were followed up for at least 3 years. Average time of follow up was 9.5 ± 0.6 years (3-17 years). The following factors were statically analyzed: age, sex, clinical symptoms, tumor location, diagnostic procedures before treatment, therapeutic method and its complications and 3-year survival. The factors influenced 3-year survival rate were also studied by Statistical Package for the Social Sciences (SPSS) version 11.5 and Fisher's exact test.
Results
40 patients were enrolled in the study, including 16 males and 24 females (M/F = 0.66). their age ranged from 12 to 88 years with a mean age of 34 years. The most common symptoms were cough (40%) and hemoptysis (25%). The prevalence of the clinical findings in carcinoid tumor patients is shown in Table 1 .
Chest X-ray and CT scan were used as diagnostic tools in all patients.
Flexible bronchoscopy was performed in all patients as a standard diagnostic procedure before treatment. A biopsy sample with a definitive pathological report was taken from 32 patients (80%); however, because of the risk of severe hemorrhage, a biopsy was not performed, and surgery was performed without biopsy on the other 8 (20%) patients.
The most common location of the tumor was in the left main bronchus (25%). Table 2 shows the prevalence of involved airways in carcinoid tumor.
Generally the tumor most commonly involved the proximal airway on the left side. Bilateral form was not observed in our study.
Thirty-eight patients (95%) underwent surgical operation. Only 2 cases (5%) showed distant metastasis on admission and did not undergo surgery. In one patient a miliary pattern of lung involvement was seen, in addition to the distant metastasis.
The most common surgical technique was lobectomy, which was performed in 14 cases (37%). Table 3 shows the prevalence of the technical procedures used in the 38 surgical cases.
We performed bronchial sleeve resection in four patients in whom three underwent bronchial sleeve upper lobectomy and one, bronchial sleeve lower lobectomy.
On pathological examination, 36 patients had the typical carcinoid form (90%) and 4 had the atypical carcinoid form (10%).
Classical mediastinal lymphadenectomy was performed on 4 patients during operation, because of mediastinal lymphatic involvement; however, in 2 patients (5%), metastatic lymphatic involvement was seen after the pathological report both of whom had the atypical carcinoid form.
Only one of the cases showed the clinical symptoms of carcinoid syndrome in which hepatic metastasis occurred.
Postoperative adjuvant therapy was required in 2 patients (5%) with atypical carcinoid form and mediastinal lymphatic involvement, (chemoradiotherapy); however, in 2 patients (5%) who had distant metastasis on admission, chemoradiotherapy was performed without an operation.
Chemotrapeutic regimens were cisplatin with etopside which was given in 6 courses with 3 weeks interval and in each course cisplaten was given with the dose of 80 mg/m 2 and etopside with the dose of 100 mg/m 2 . The dosage of radiotherapy was 5000 rad which was given in 5 weeks (5 times each week).
Also in cases with unresectable tumor and in patients who could not tolerate surgery, the dosage of radiotherapy was enhanced, but only if the tumor has an acceptable response to it.
Postoperative recurrence was seen in form of distant metastasis in one case (2.5%) in atypical carcinoid form with mediastinal lymphatic involvement. 37 (92.5%) patients had no recurrence after surgery.
In the 3-year evaluation for survival, 37 patients (92.5%) were still alive while 3 (7.5%) patients died, in whom 2 cases had distant metastasis at the time of admission and one patient went to the US, 1.5 years after the initial surgery with distant metastasis. All the patients who underwent sleeve resection were still alive with no sign of recurrence on follow up.
Regarding factors affecting the survival, patients were placed into two groups (more and less than 3 years survival), and were evaluated for parameters such as age, sex, side of involvement, type of pathology, mediastinal lymph node involvement and distant metastasis (early and late). All patients with typical carcinoid were alive after 3 years and only one patient with atypical carcinoid was alive after 3 years which shows that type of pathology affects survival (P <0.05). Other factors such as mediastinal lymph node involvement (P = 0.001) and early distant metastasis (P = 0.004) were also effective on survival, but other factors were not meaningful statistically. Table 4 shows the role of various factors in the survival of 40 patients with carcinoid tumors.
We also determined 3 years survival according to Kaplan Meier method for the patients whom underwent appropriate treatment (Fig. 1) .
Postoperative complications were seen in 6 (15.6%) out of 38 patients and the most common were: prolonged air leakage in 4 patients (10.5%) which was controlled with conservative treatments (use of low suction), and wound infection in 2 patients (5.2%) which responded to usual treatments (opening the wound, washing and secondary repair).
In one patient who had been discharged, empyema occurred after 3 months because of persistent space formation (from the prolonged air leakage group), and it was controlled by operation and using decortications and muscular flap. No surgical mortality occurred.
Discussion
Carcinoid tumors are malignant neuroendocrine tumors, first described in 1888 in the ileum. When neuroendocrine cells were first discovered, they were called clear cells and, later, amine precursor uptake and decarboxylation (APUD) system cells. The term neuroendocrine was introduced because of capability to synthesizing hormonal products and numbers of these products are identical to the nervous system. 2) Carcinoid tumors can be placed in the spectrum of neuroendocrine tumors, from low grade malignant typical carcinoids to intermediate atypical carcinoid to high grade small cell lung cancer (SCLC).
3) Bronchial carcinoids occur in any age but usually in the middle of 5th-decade of life equally in both sexes. 4) In our study the median age was 34 years and male to female ration was 0.66.
In a study performed by Modlin et al, 25% of patient's were asymptomatic but in the symptomatic cases cough and hemoptysis were the most common symptoms. 5) In our study all the patients were symptomatic and cough and hemoptysis were the most common symptoms. Bronchial carcinoids mostly occur in major airways (central airways). These tumors are highly vascular and originate submucusally. The carcinoid syndrome is rare, presents at diagnosis (1%-2% incidence) and is severe in patients with large primary tumors or extensive hepatic metastases. 6) Diagnosis is usually established by fibreoptic bronchoscopy and biopsy, although it can occasionally result in severe hemorrhage. 7) In our study the most common location of tumor was in the left main bronchus, and only one case (2.5%) showed the clinical symptoms of carcinoid syndrome with hepatic metastasis. All patients underwent flexible bronchoscopy but the biopsy was taken in 80% of patients before surgery. But because of the occurrence of severe hemorrhage, biopsy was not performed, and surgery performed without biopsy in (20%) patients.
Biological behavior and prognosis of bronchial cacinoid tumors are better than other lung cancers.
8) The best method in treatment of carcinoid tumors is surgical resection with lymph node sampling. Surgery and long terms outcome are significantly related to histological type, node involvement and pathological status. 9) Because of the central localization of these tumors, for saving the pulmonary parenchyma, sleeve resection was performed in these tumors. Sleeve resection achieves local tumor control and is associated with a low mortality and bronchial anostomatic complication rate as well as excellent long term survival. 10) In our study, 38 patients (95%) underwent surgical operation, and lobectomy was the most common surgical technique (37%). Sleeve resection was performed in (10.4%) of patient with excellent long term results with no mortality or recurrence. All patients in whom sleeve resection was performed had typical carcinoid tumor.
A study comparing typical and atypical carcinoid tumors showed that typical carcinoid tumors had more significant endobronchial polypoid growth and better survival than atypical carcinoid tumors, but mediastinal lymph node involvement had been more significant in atypical carcinoid tumors. 11) Patients with atypical carcinoid tumors and regional lymph node metastasis have a high likelihood of developing recurrent disease, if treated with surgical resection alone, and have a significantly worse outcome. 12) In our study, 90% of patients had typical carcinoid form but mediastinal lymph node involvement was seen in 2 patients with atypical carcinoid tumor with worse prognosis than the typical carcinoid tumor.
Although surgery remains the standard of treatment for operable disease, histology is the most important factor in determining the role of adjuvant therapy. Completely resected typical or atypical carcinoid tumors without mediastinal lymph node involvement do not require adjuvant therapy but resected atypical carcinoid with mediastinal lymph node involvement or unresectable cases requires adjuvant therapy. 13) In our study, post operative adjuvant therapy was performed in atypical carcinoid tumors with positive mediastinal lymph node involvement in 2 patients (5%) and in those with metastatic lesions on admission in 2 patients (5%)
In a Spanish multicentric study (2007) histology and node involvements appeared as the most important factors influencing the prognosis. 14) In another studies histological type, pathological stage and lymph node involvement affected the prognosis. 8, 15) In our study, histology, lymph node involvement and early distant metastasis appeared as the most important factors affecting the prognosis.
Conclusion
Based on good postoperative results in carcinoid tumor patients, surgical resection has been the treatment of choice in these tumors. Factors which appear to influence the prognosis are the pathological form, mediastinal lymph node involvement and distant metastasis in carcinoid tumor patients.
